Affinity Chromatography Carrier with Carboxy Groups for Antibody Purification

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current affinity chromatography carriers, such as those with cation exchange and affinity ligands, face challenges in achieving high purification purity and antibody adsorption capacity, particularly in reducing non-specific adsorption and improving the removal of host cell proteins from antibody drugs.

Innovation Solution

An affinity chromatography carrier is developed with a substrate of crosslinked cellulose, agarose, or acrylate-based polymers, coated with hydrophilic polysaccharides like dextran, and incorporating a carboxy group with an ion exchange capacity of 15-60 mmol/L-gel, along with an antibody-binding protein like protein A, to enhance antibody adsorption and purification purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If a cation exchange chromatography carrier with affinity ligands is used, then antibody adsorption capacity is improved, but purification purity deteriorates due to non-specific adsorption

Engineering Contradiction:
Improveantibody adsorption capacityVSAvoidpurification purity
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent applies local quality by creating distinct functional zones on the carrier surface: hydrophilic polymer regions that reduce non-specific adsorption and cation exchange groups that provide selective binding. The hydrophilic polymer is grafted specifically at the surface region to minimize non-specific interactions, while cation exchange groups are distributed to provide selective antibody binding, thereby resolving the contradiction between adsorption capacity and purification purity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent employs composite materials by combining hydrophilic polymers (such as polyethylene glycol or polyvinyl alcohol) with cation exchange functional groups on the carrier surface. This composite structure integrates the non-specific adsorption-reducing properties of hydrophilic polymers with the selective binding capabilities of cation exchange groups, simultaneously achieving high antibody adsorption capacity and high purification purity.

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If the ion exchange capacity is increased to improve purification purity, then non-specific adsorption is reduced, but antibody adsorption capacity deteriorates

Engineering Contradiction:
Improvepurification purityVSAvoidantibody adsorption capacity
Core Design Contradiction:
Manufacturing precisionVSQuantity of substance

Solution Approach 1:

The patent applies parameter changes by optimizing the ion exchange capacity within a specific range of 10-50 mmol/L-gel and controlling the hydrophilic polymer grafting density. By precisely adjusting these parameters, the patent achieves a balance where sufficient cation exchange capacity reduces non-specific adsorption while maintaining adequate antibody adsorption capacity through optimized functional group distribution and hydrophilic polymer content.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The carrier effectively reduces non-specific adsorption, improves purification purity, and maintains high antibody adsorption capacity, leading to enhanced productivity and quality in antibody drug production by specifically binding antibodies while minimizing host cell protein contamination.

Implementation Method 1

a carboxy group is introduced into the affinity chromatography carrier, and the amount of the carboxy group introduced is 15 mmol/L-gel to 60 mmol/L-gel in terms of ion exchange capacity

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 2

an affinity ligand is at least one selected from the group consisting of an antibody-binding protein and an antibody-binding polypeptide

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Data Source

PatentEP3367093B1Affinity chromatography carrier and its use in a biological substance purification method
Publication Date: 2021.11.03 FUJIFILM CORP
  • EP3367093B1 patent drawing
  • EP3367093B1 patent drawing
  • EP3367093B1 patent drawing

AI summary

Provided is an affinity chromatography carrier having an excellent purification purity, including a substrate, a hydrophilic polymer, and an affinity ligand, in which the substrate is constituted of at least one selected from the group consisting of a polysaccharide, an acrylate-based polymer, a methacrylate-based polymer and a styrene-based polymer, the hydrophilic polymer is at least one selected from the group consisting of hydrophilic polysaccharides, the affinity ligand is at least one selected from the group consisting of an antibody-binding protein and an antibody-binding polypeptide, a carboxy group is introduced into the affinity chromatography carrier, and the amount of the carboxy group introduced is 15 mmol/L-gel to 60 mmol/L-gel in terms of ion exchange capacity.